Development

Cytoguide has identified its first medical indication within inflammation and produced  the first humanized antibody conjugate drug for anti-inflammatory therapy.

Cytoguide has obtained proof of concept in animal models for the unique combination of high efficacy/low side-effects characterising the Cytoguide platform.